Core Viewpoint - Aosaikang's stock price experienced a decline on August 15, closing at 26.35 yuan, down 0.68% from the previous trading day [1] Company Overview - Aosaikang's main business is in the pharmaceutical manufacturing industry, accounting for 97.92% of its operations [1] - The company is involved in the chemical pharmaceutical sector and has capabilities in innovative drug research and development [1] Financial Performance - In the first quarter of 2025, Aosaikang achieved a revenue of 509 million yuan and a net profit of 54.73 million yuan [1] Shareholder Activity - The major shareholder, Yiwai Holdings Co., Ltd., plans to reduce its stake by up to 18.56 million shares, representing 2% of the total share capital, starting from September 6 for three months [1] - Yiwai currently holds approximately 120 million shares, which is 12.95% of the total share capital [1] Market Activity - On August 15, the net inflow of main funds was 3.49 million yuan, accounting for 0.01% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow of main funds was 16.62 million yuan, representing 0.07% of the circulating market value [1]

证券代码：002846 证券简称：英联股份 公告编号：2025-057 广东英联包装股份有限公司 关于公司股东提前终止减持计划 暨权益变动触及 1%整数倍的公告 公司股东蔡沛侬女士及其一致行动人、公司持股 5%以上股东翁伟炜先生及其一致 行动人保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 本公司及全体董事会成员保证公告内容与信息披露义务人提供的信息一致。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 宗交易方式合计减持公司股份不超过 10,458,200 股（即总股本 1 的 2.50%）。截 至本公告披露日，蔡沛侬女士通过集中竞价方式累计减持 4,183,200 股（即总股 本 1 的 1%)，另外 6,275,000 股（即总股本 1 的 1.50%）未进行减持操作；翁伟炜 先生通过集中竞价、大宗交易方式累计减持 5,410,200 股（即总股本 1 的 1.29%)， 另外 5,048,000 股（即总股本 1 的 1.21%）未进行减持操作；蔡沛侬女士、翁伟炜 先生经综合考虑决定提前终止本次减持计划，剩余未减持股份在本次减持计划期 ...

博力威公告，因自身资金需求，公司实际控制人、董事长张志平及其一致行动人博广聚力和乔戈里计划 通过集中竞价交易方式或大宗交易方式减持其所持有的公司股份。张志平拟减持股份数量合计不超过 237.56万股，占公司总股本的比例不超过2.35%；博广聚力拟减持股份数量合计不超过25.78万股，占公 司总股本的比例不超过0.25%；乔戈里拟减持股份数量合计不超过40.10万股，占公司总股本的比例不超 过0.40%。上述减持计划将自本公告披露之日起15个交易日后的3个月内实施。 ...

Group 1 - The core point of the news is that the controlling shareholder of Rejing Bio, Lin Changqing, plans to reduce his shareholding due to personal funding needs, which will not affect the company's control or stable operations significantly [1] - Lin Changqing intends to reduce his holdings by up to 1,000,000 shares, representing 1.0787% of the total share capital, through centralized bidding and block trading [1] - As of the announcement date, Lin Changqing holds 21,682,487 shares, accounting for 23.39% of the company's total shares [1] Group 2 - In 2024, Rejing Bio reported total revenue of 51,089.06 million yuan, a decrease of 7.62% year-on-year [3] - The net profit attributable to the parent company was -17,923.07 million yuan, compared to a profit of 2,851.62 million yuan in the same period of 2023 [3] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 30, 2019, with an issuance of 15,550,000 shares at a price of 29.46 yuan per share [3]

中国经济网北京8月15日讯君实生物(688180.SH)昨晚披露了关于持股5%以上股东减持股份计划的公 告。 截至公告披露日，上海檀英投资合伙企业(有限合伙)(以下简称"上海檀英")持有君实生物股份 （600201）71,459,326股，股份性质为A股，占公司总股本的6.9602%。上述股份为公司首次公开发行股 票并在上海证券交易所科创板上市(以下简称"IPO")前取得的股份，且已于2021年7月15日起解除限售并 上市流通。 上海檀英长期看好公司的发展，因基金期限与流动性资金安排原因，计划通过大宗交易的方式减持其持 有的公司股份数量不超过20,533,797股，减持比例不超过公司总股本的2%。上海檀英为在中国证券投资 基金业协会备案的私募基金，已成功申请适用《上市公司创业投资基金股东减持股份的特别规定》和 《上海证券交易所上市公司创业投资基金股东减持股份实施细则》的减持政策：拟通过大宗交易方式减 持的，在任意连续60日内减持股份的总数不超过公司总股本的2%，自公告披露之日起15个交易日后的 三个月内进行。 上述股份的减持价格按市场价格确定，若减持期间公司发生派息、送股、资本公积金转增股本、配股等 除权除息 ...

Core Viewpoint - The controlling shareholder and actual controller of Yuhuan CNC Machine Tool Co., Ltd., Mr. Xu Shixiong, plans to reduce his shareholding by up to 1,558,000 shares, accounting for 1% of the company's total share capital, within a three-month period starting from September 5, 2025, due to personal funding needs [3][4][10]. Group 1: Shareholder Information - The controlling shareholder, Mr. Xu Shixiong, holds 50,534,900 shares, representing 32.43% of the company's total share capital [3]. - The reduction plan is in compliance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [3][10]. Group 2: Reduction Plan Details - The reduction is planned to occur through centralized bidding transactions [5]. - The specific reduction period is from September 5, 2025, to December 4, 2025, with the possibility of suspension during legal window periods [4][10]. - The selling price will be determined based on market conditions at the time of the reduction [5]. Group 3: Compliance and Commitments - Mr. Xu has made commitments regarding shareholding intentions and reduction plans in the company's initial public offering documents, including a lock-up period and conditions for share transfer [6][7]. - He has pledged that any gains from non-compliance with these commitments will be returned to the company [8][9]. - The company has confirmed that there are no circumstances that would prevent Mr. Xu from proceeding with the planned reduction [10].

张小泉股价报19.93元，较前一交易日下跌0.15元。盘中最高触及20.14元，最低下探至19.81元，成交额 0.31亿元。 8月13日主力资金净流出11.55万元，近五个交易日累计净流出1114.2万元。 风险提示：股市有风险，投资需谨慎。 公司主营业务为刀剪及厨房五金制品的研发、生产和销售。2025年一季度实现营业收入2.25亿元，净利 润1299万元。 公司股东金燕计划以集中竞价方式减持不超过54.01万股，占公司总股本的0.36%。减持计划将在公告披 露后三个交易日起三个月内实施。 ...

天利科技（300399）公告，股东钱永耀因自身资金需要，计划自公告披露之日起15个交易日后的90天 内，通过集中竞价或大宗交易方式减持公司股份不超过592.8万股，占公司总股本3%。截至公告日，钱 永耀持有公司股份2621.16万股，占13.26%。其中采用集中竞价方式的，在任意连续90个自然日内减持 比例不超过1%；采用大宗交易方式的，在任意连续90个自然日内减持比例不超过2%。减持股份来源为 首次公开发行前股份及资本公积金转增股本获得的股份，价格按届时市场价确定。 ...

利君股份公告，持股5%以上股东魏勇及其一致行动人安信证券资管－魏勇－安信资管创赢29号单一资 产管理计划合计持有1.32亿股，占12.80%。二者计划自2025年9月5日至2025年12月4日，采用集中竞价 方式减持不超过1033.46万股，占1%；采用大宗交易方式减持不超过2066.92万股，占2%。 ...

三友医疗8月13日晚间公告，公司实际控制人之一、董事兼总裁徐农的一致行动人混沌天成资管－徐农 －混沌天成精选策略18号单一资产管理计划计划自2025年9月8日至2025年12月7日，通过大宗交易方式 减持公司股份不超过666.92万股，即不超过公司总股本的2%。减持原因为个人资金需求。本次减持计 划实施具有不确定性。 ...